(Q33965331)

30 July 2017

title

Recurrent episodes of skin angioedema and severe attacks of abdominal pain induced by oral contraceptives or hormone replacement therapy (English)

1 reference

30 July 2017

Konrad Bork

1

1 reference

30 July 2017

Bettina Fischer

series ordinal

2

1 reference

30 July 2017

Georg Dewald

series ordinal

3

1 reference

30 July 2017

language of work or name

English

0 references

publication date

1 March 2003

1 reference

American Journal of Medicine

30 July 2017

published in

1 reference

30 July 2017

volume

114

1 reference

30 July 2017

issue

4

1 reference

30 July 2017

page(s)

294-298

1 reference

Hereditary angioedema: a broad review for clinicians

30 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2802%2901526-7

Detection of C1 inhibitor mutations in patients with hereditary angioedema.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2802%2901526-7

A review of the reported defects in the human C1 esterase inhibitor gene producing hereditary angioedema including four new mutations.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2802%2901526-7

Hereditary angioedema with normal C1-inhibitor activity in women

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2802%2901526-7

Clinical, biochemical, and genetic characterization of a novel estrogen-dependent inherited form of angioedema

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2802%2901526-7

Hereditary Angioedema: the Clinical Syndrome and Its Management

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2802%2901526-7

Recurrent angioedema: familial and oestrogen-induced

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2802%2901526-7

[Contraception and pregnancy in hereditary angioedema]

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2802%2901526-7

Hereditary angioedema and oral contraception

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2802%2901526-7

Hormonally exacerbated hereditary angioedema

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2802%2901526-7

Hereditary angio-oedema: new clinical observations and autoimmune screening, complement and kallikrein-kinin analyses.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2802%2901526-7

Type I hereditary angio-oedema. Variability of clinical presentation and course within two large kindreds.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2802%2901526-7

Coexistence of hereditary angioedema and Turner's syndrome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2802%2901526-7

Hereditary angioedema type III: an additional French pedigree with autosomal dominant transmission

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2802%2901526-7

Angioneurotic edema from an oral contraceptive

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2802%2901526-7

Effect of time, temperature and additives on a functional assay of C1 inhibitor

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2802%2901526-7

HEREDITARY ANGIO-NEUROTIC ŒDEMA

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2802%2901526-7

A BIOCHEMICAL ABNORMALITY IN HEREDIATRY ANGIONEUROTIC EDEMA: ABSENCE OF SERUM INHIBITOR OF C' 1-ESTERASE.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2802%2901526-7

HEREDITARY ANGIONEUROTIC EDEMA: TWO GENETIC VARIANTS.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2802%2901526-7

Effect of sex hormones on the complement-related clinical disorder of hereditary angioedema

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2802%2901526-7

Plasma bradykinin in angio-oedema.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2802%2901526-7

Increased vascular permeability in C1 inhibitor-deficient mice mediated by the bradykinin type 2 receptor

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2802%2901526-7

Pathways for bradykinin formation and inflammatory disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2802%2901526-7

Contact factors in plasma from women on oral contraception--significance of factor XI for the measured activity of factor XII

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2802%2901526-7

Estrogen induction and contact phase activation of human factor XII.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2802%2901526-7

Hormone replacement therapy and serum angiotensin-converting-enzyme activity in postmenopausal women

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2802%2901526-7

Effects of estrogen replacement therapy on the renin-angiotensin system in postmenopausal women

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2802%2901526-7

Effect of long-term hormone replacement therapy on angiotensin-converting enzyme activity and bradykinin in postmenopausal women with essential hypertension and normotensive postmenopausal women

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2802%2901526-7

10.1016/S0002-9343(02)01526-7

7 January 2021

Identifiers

DOI

1 reference

30 July 2017

1 reference